Nanosphere (NSPH +3.5%) moves higher today after the FDA granted 510(k) clearance for the...
Tuesday, November 13, 2012, 12:32 PM ETNanosphere (NSPH +3.5%) moves higher today after the FDA granted 510(k) clearance for the marketing of its CYP2C19 Nucleic Acid Test on the automated sample-to-result Verigene System. The test is used as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway by identifying variations directly from a patient's whole blood sample in less than 2.5 hours.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles